Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sumatriptan--side effects and problems in routine clinical practice]

A Marterer1, C Wöber, P Schnider

  • 1Neurologiche Universitätsklinik Wien.

Medizinische Klinik (Munich, Germany : 1983)
|November 15, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reliability of assessing lifestyle and trigger factors in patients with migraine--findings from the PAMINA study.

European journal of neurology·2015
Same author

Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK₁ and NK₃ receptors.

British journal of pharmacology·2010
Same author

The course of migraine-a diary study in unselected patients.

Cephalalgia : an international journal of headache·2009
Same author

Cutaneous allodynia during cluster headache attacks.

Cephalalgia : an international journal of headache·2009
Same author

Quality of sleep, fatigue and daytime sleepiness in migraine - a controlled study.

Cephalalgia : an international journal of headache·2009
Same author

First Austrian case of hypnic headache: serial polysomnography and blood pressure monitoring in treatment with indomethacin.

Cephalalgia : an international journal of headache·2008
Same journal

Medizinische Klinik (Munich, Germany : 1983)·2020
Same journal

Medizinische Klinik (Munich, Germany : 1983)·2020
Same journal

Medizinische Klinik (Munich, Germany : 1983)·2020
Same journal

[Not Available].

Medizinische Klinik (Munich, Germany : 1983)·2016
Same journal

[Not Available].

Medizinische Klinik (Munich, Germany : 1983)·2016
Same journal

[Not Available].

Medizinische Klinik (Munich, Germany : 1983)·2014
See all related articles

Sumatriptan effectively treats migraine and cluster headaches. While generally safe, careful patient selection is crucial to minimize risks of adverse events, especially in those with contraindications or drug abuse history.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Sumatriptan is a widely used medication for acute headache treatment.
  • Understanding its real-world efficacy and safety is essential for clinical practice.

Purpose of the Study:

  • To evaluate the efficacy and adverse events of sumatriptan in daily clinical practice.
  • To identify potential risk factors associated with sumatriptan use.

Main Methods:

  • A survey of 72 outpatients treated with sumatriptan for headaches.
  • Patients were diagnosed with migraine, cluster headache, or tension-type headache according to International Headache Society criteria.

Main Results:

  • Sumatriptan was found effective for migraine and cluster headache, consistent with literature.

Related Experiment Videos

  • Adverse events were reported by 69% of patients, higher than in clinical trials, but usually mild and transient.
  • Adverse events were more frequent in migraine patients and may not always be therapy-related.

    • Conclusions:

    • Sumatriptan is effective for acute migraine and cluster headaches.
    • Severe adverse events, particularly cardiac ones, can occur if contraindications are ignored.
    • Sumatriptan requires careful diagnosis and prescription, excluding patients with drug abuse potential.